David Skurnik at University of Paris - Research Interests, Publications & Academic Profile

David Skurnik

Full Professor of Medicine

Université Paris Cité

France

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

40%

Microbiology

60%

Immune Response

40%

Covid-19

40%

Bacterial Infection

20%

Sars-cov-2

20%

Bacterial Genetics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

TnSeq Vaccinology: from pathophysiology studies to multivalent vaccine design – Seq-N-Vac

Open Date: 2021-02-20

Close Date: 2025-02-19

Grant: Close

Extended spectrum antibodies against MDR and pan-resistant bacteria – ESAAM

Open Date: 2021-01-20

Close Date: 2024-01-19

Grant: Close

Mechanistic evaluation of the interaction between Enterobacteriaceae and fungi in the context of gut inflammation – Enterofun

Open Date: 2020-01-20

Close Date: 2023-07-19

Articles12

A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens

Article Link

Year:

2024

Maternal immune factors involved in the prevention or facilitation of neonatal bacterial infections

Article Link

Year:

2024

How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?

Article Link

Year:

2023

A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonates.

Article Link

Year:

2023

Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region.

Article Link

Year:

2022

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance.

Article Link

Year:

2022

A qnrD-Plasmid Promotes Biofilm Formation and Class 1 Integron Gene Cassette Rearrangements in Escherichia coli

Article Link

Year:

2022

A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli.

Article Link

Year:

2022

Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.

Article Link

Year:

2021

Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.

Article Link

Year:

2021

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Article Link

Year:

2021

Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis

Article Link

Year:

2021

Collaborators12

Fany Reffuveille

Lecturer-researcher

Université de Reims Champagne-Ardenne

FRANCE

Johannes Huebner

Deputy Physician-in-Chief

LMU Klinikum

GERMANY

Victoire de Lastours

Professor

Université Paris Diderot

FRANCE

Patrycja Nowak-Sliwinska

Associate professor in Molecular Pharmacology

University of Geneva

SWITZERLAND

JEROME ROBERT

Professeur

Sorbonne Université Faculté de Médecine

FRANCE

vincent jarlier

professor in medicine

Sorbonne Université

FRANCE

Christophe De Champs

Professor

Université de Reims Champagne-Ardenne

FRANCE

Jean-Louis Herrmann

Director/Professor

Université de Versailles Saint-Quentin-en-Yvelines

FRANCE

Martin Rottman

Professeur des Universités Praticien Hospitalier

Assistance Publique - Hôpitaux de Paris

FRANCE

Xavier Nassif

Professor

Université Paris Cité

FRANCE

Anaelle Muggeo

Université de Reims Champagne-Ardenne

FRANCE

Thomas Guillard

Professor of Medicine

FRANCE

How do Indian students reach out?

Meet Kite AI